Curis Lifesciences Complete Financial Statements

In FY2024, Curis Lifesciences (CURIS) reported revenue ₹9 Cr, net profit ₹1 Cr and EPS ₹24.00, with a net profit margin of 11.1% and ROE of 6.3%. Full financial statements from FY2022 to FY2025 (4 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see CURIS stock price BSE.

4 Years of Data
2025 - 2022

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 11.11% 2024 data
EBITDA Margin 33.33% 2024 data
Operating Margin 30.00% 2024 data
Return on Assets 2.33% 2024 data
Return on Equity 6.25% 2024 data

Balance Sheet Ratios

Current Ratio 3.44 2024 data
Equity Ratio 37.21% 2024 data
Asset Turnover 0.21 2024 data

CURIS Revenue, Net Profit & EBITDA — Year-on-Year Growth

CURIS YoY.

Assets Growth
+26.5%
Year-over-Year
Equity Growth
+166.7%
Year-over-Year

CURIS Income Statement — Revenue, EBITDA & Net Profit

Curis Lifesciences revenue ₹9 Cr, EBITDA ₹3 Cr, net profit ₹1 Cr, EPS ₹24.00 (2024) — net profit margin 11.1%. Explore CURIS investment value to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars Jun 2024
Revenue 9
Expenses 6
EBITDA 3
Operating Profit Margin % 30.00%
Depreciation 0
Interest 0
Profit Before Tax 2
Tax 1
Net Profit 1
Earnings Per Share (₹) 24.00

CURIS Balance Sheet — Assets, Liabilities & Shareholders' Equity

CURIS total assets ₹43 Cr, total equity ₹16 Cr, total liabilities ₹ Cr (2025) — ROE 6.3%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022
ASSETS
Total Assets 43 34 30 27
Current Assets 31 22 17 15
Fixed Assets 11 12 12 12
Capital Work in Progress 0 0 0 0
Investments 0 0 0 0
Other Assets 32 22 18 15
LIABILITIES
Total Liabilities
Current Liabilities 9 10 10 13
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 16 6 0 -1
Share Capital 6 1 1 1
Reserves & Surplus 10 5 0 -1

CURIS Cash Flow Statement — Operating, Investing & Financing

Curis Lifesciences operating cash flow ₹-2 Cr, investing ₹0 Cr, financing ₹2 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022
Operating Activities -2 0 3 5
Investing Activities 0 0 -1 0
Financing Activities 2 0 -3 -5
Net Cash Flow 0 0 0 0